Quest Diagnostics (DGX) Depreciation & Amortization (CF) (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Depreciation & Amortization (CF) data on file, last reported at $147.0 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 5.0% year-over-year to $147.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $577.0 million (up 11.61% YoY) and the FY2025 annual result came in at $570.0 million, up 15.62% from the prior year.
• Depreciation & Amortization (CF) improved to $147.0 million in Q1 2026 per DGX's latest filing, from $145.0 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $147.0 million in Q1 2026, with the low at $106.0 million in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $122.7 million, with a median of $116.0 million recorded in 2022.
• Year-over-year, Depreciation & Amortization (CF) declined 6.03% in 2023 and gained 23.85% in 2024.
• Quest Diagnostics' Depreciation & Amortization (CF) stood at $116.0 million in 2022, then dropped by 6.03% to $109.0 million in 2023, then advanced by 23.85% to $135.0 million in 2024, then gained by 7.41% to $145.0 million in 2025, then rose by 1.38% to $147.0 million in 2026.
• Business Quant data shows DGX's Depreciation & Amortization (CF) at $147.0 million in Q1 2026, $145.0 million in Q4 2025, and $142.0 million in Q3 2025.